![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 20, 2013 7:26:23 AM
It hurts the company that is trying to bring the indication to market because it makes it so much more difficult to raise funds at a reasonable price... selling their shares on the cheap... or in desperate times turning to toxic financing options... it hurts the companies...
Which means that ultimately it hurts the cancer patient... because heavy shorting and market manipulation make it more difficult to bring an indication to market... there will be fewer indications... fewer treatment options...
One's heart is never far from one's wallet... for most of us humans anyway... so when one makes a living shorting small biotechs... one's heart is routinely rooting for failure of their treatment indications... which whether we know it or not, admit it or not, means we are ultimately rooting against the cancer patient... over time... if one does this a lot over time... does it begin to make that person small and cynical... I wonder...
I understand the short game and the market manipulation... I take advantage of it myself by buying low... I am not claiming moral superiority... I just don't think I want to make a living or become wealthy by rooting against cancer patients...
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM